Cardiology

Discover the higher risk of heart failure with pregabalin versus gabapentin in older adults. Read the full study findings.

Early cardiac rehabilitation did not improve function or rehospitalisation in severe heart failure, but mobility gains were seen.

Adults later diagnosed with cardiovascular disease show declining activity years before onset, highlighting the importance of lifelong exercise.

Tirzepatide improves outcomes in heart failure with obesity, with greatest physical benefits seen in those with higher BMI.

US heart deaths have dropped since 1970, but deaths from heart failure and arrhythmias are on the rise.

Discover how LMNA gene variant type and position impact cardiomyopathy risk—keep reading for clinical implications and treatment guidance.

Delayed hypertension diagnosis increases cardiovascular risk and lowers treatment rates, underscoring the value of prompt clinical action.

Discover how bedtime antihypertensive dosing benefits blood pressure control. Keep reading for clinical insights and recommendations.

AI screening from a single echocardiographic clip accurately detects cardiac amyloidosis, surpassing traditional diagnostic methods.

MAARS uniquely integrates electronic health records, imaging reports, and contrast-enhanced cardiac MRI using a transformer-based neural network.

GLP-1 receptor agonists cut heart, stroke, and kidney risks in people with MGUS and diabetes, new study finds.

Find out how epinephrine administration routes impact survival in paediatric cardiac arrest—explore the latest evidence now.

AI now matches experts in echocardiogram interpretation, promising faster, more accessible heart diagnostics for all patients.

Finerenone benefits heart failure patients with preserved ejection fraction, regardless of frailty, supporting its wider clinical use.

Edoxaban and rivaroxaban show best balance of efficacy and safety in elderly patients with atrial fibrillation.

Patients with atrial fibrillation now live longer after stroke, heart failure, or myocardial infarction, but bleeding risks remain unchanged.

Loneliness increases heart disease risk by 15% in both US and South Korea, major study finds.

Beta-blocker interruption after heart attack raises blood pressure and heart rate, increasing risks especially in hypertensive patients.

Timing doesn’t matter! Study finds no added heart benefit from bedtime blood pressure meds.

Understand how the DASH diet significantly lowers the risk of colorectal cancer, supporting dietary changes for cancer prevention.

Discover how yoga may reduce blood pressure, but further investigation is needed to validate these results.

SGLT2 inhibitors reduce hyperkalemia risk, aiding RAASi continuity in high-risk patients.

A new study has revealed a potential link between live zoster vaccination and a reduced risk of cardiovascular disease.

New risk model predicts hyperkalaemia in CKD and diabetes, enabling tailored care and safer treatment decisions for patients.

Pregnancies with mechanical heart valves carry high risks, as a global registry reveals stark outcomes.

Rising systolic blood pressure variability increases risks of heart disease, kidney disease, and death.

Blood pressure control over 48 months cuts dementia risk by 15% in a large clinical trial.

Clinical trial results reveal that etripamil cuts emergency department visits by 39% inpatients with paroxysmal supraventricular tachycardia.

Early GDMT goals, especially blood pressure control, reduce the risk of CV events in chronic coronary disease.

New study shows all ADHD medications, not just stimulants, affect cardiovascular parameters in children, adolescents, and adults.

Wearable ECG shirt monitors heart rate recovery, predicting cardiovascular risk with 86% accuracy in new study.

Research reveals that hypertensive pregnancy disorders double dilated cardiomyopathy risk; highlighting that vigilance is needed postpartum.

Genetic study with 796,722 participants reveals that remnant cholesterol drives PAD risk independently.

Discover how 60 genes drive congenital heart disease. Learn how genetic testing improves outcomes.

OAC discontinuation post-catheter ablation for AF reduces bleeding but increases thromboembolic risk.

A new study shows that compound heatwaves drive linear cardiac mortality risks, surpassing daytime/night-only events.

New research shows how the FAB Score predicts mortality risk in adult Fontan patients with 92% accuracy.

Machine learning model predicts death risk in broken heart syndrome with 84% accuracy, a new study reveals.

Novel metabolic accelerator HU6 reduces fat mass without muscle loss in obesity-related heart failure patients.

Research suggests statins significantly reduce liver cancer and decompensation risk in chronic liver disease patients, especially with prolonged use.

Quitting alcohol raises bad cholesterol while lowering good cholesterol, study finds.

SCAD study flags risky blood thinners, fibromuscular dysplasia as predictors of heart complications. Urges treatment rethink.

Butter linked to higher mortality; plant-based oils reduce death risks. Study urges dietary swaps for long-term health.

Long-term study reveals alarming cardiovascular risks in steroid users, with some heart conditions up to nine times more likely.

Study finds no increased risk of major cardiovascular events with nicotinamide use but highlights risks for prior MACE patients.

Arterial stiffness, measured by pulse wave velocity, is more strongly linked to ageing than short-term blood pressure variability.

New study finds the PERIXa protocol for perioperative anticoagulation in AF patients undergoing low-risk procedures is safe.

Myocardial fibrosis predicts mortality after aortic valve replacement, highlighting its importance for risk assessment in aortic stenosis.

A groundbreaking study from the European Society of Cardiology suggests that pregnancy in women with peri-partum cardiomyopathy (PPCM) may not be as high-risk as previously believed.

Tirzepatide reduces LV mass and paracardiac fat in obesity-related HFpEF, offering structural heart benefits beyond weight loss.

Olpasiran significantly lowers oxidized phospholipids on apolipoprotein B but has no impact on systemic inflammatory markers in cardiovascular disease.

Minimally invasive endoscopic ultrasound-guided radiofrequency ablation offers a safe and effective alternative to adrenalectomy for treating unilateral aldosterone-producing adenomas.

A large Spanish cohort study highlights the distinct clinical features, management, and outcomes of coagulase-negative staphylococcal endocarditis.

Study reveals distinct clinical features in patients with both cardiac sarcoidosis and ACM-associated genetic variants, aiding diagnosis.

Younger patients with hypertrophic cardiomyopathy face increased sudden cardiac death risk during high-intensity exercise, despite no link to traditional risk factors.

A novel cardiovascular risk score improves prediction of heart disease by assessing stress-related changes in vascular function.

The 2025 AHA report highlights ongoing disparities in cardiovascular health, urging clinicians to enhance prevention and early intervention efforts.

Engineered heart muscle allografts safely remuscularize failing hearts, showing promise for heart failure treatment in primates and humans.

Women with permanent atrial fibrillation face a higher risk of heart failure than men, highlighting sex-specific risk factors.

Discover AROSE, a new equation to better predict ASCVD risk in individuals with obesity, outperforming current models.

Reduced placental flow and malperfusion defects in fetuses with CHD highlight potential pathways impacting growth and outcomes.

PTSD worsens endothelial function in women with HIV, a key cardiovascular risk factor. Early screening could improve outcomes.

Small heart size increases mortality risk in normal ejection fraction individuals, especially women and high-normal LVEF patients.

AI model automates heart failure identification, offering precision and paving the way for improved quality assessments.

Echocardiographic donor heart size matching improves heart transplant outcomes, outperforming traditional methods, especially for obese recipients.

Aspirin avoidance in patients with HeartMate 3 LVAD reduces bleeding risk without increasing thrombosis, even with vascular conditions.

Pregnancy does not increase long-term risks of mortality or adverse outcomes in individuals with hypertrophic cardiomyopathy.

Tafamidis reduces mortality and slows cardiac deterioration in ATTR-CM, improving imaging and clinical outcomes.

Study finds anti-CGRP mAbs do not increase cardiovascular risk in older or disabled patients with migraine.

Study links type 2 diabetes to impaired fibrous repair in atherosclerotic plaques, highlighting new treatment possibilities.

AI-enhanced ECG predicts hypertension and identifies patients at risk for adverse events, transforming preventive care approaches.

Chronic air pollution exposure significantly raises the risk of venous thromboembolism, underscoring its health impacts and clinical relevance.

AAS use may cause persistent coronary microvascular dysfunction, even years after cessation, highlighting long-term cardiovascular risks.

Aficamten improves symptoms, biomarkers, and quality of life in nonobstructive hypertrophic cardiomyopathy, promising better treatment options.

Exploring how cardiovascular imaging can better address the unique risks and outcomes of heart disease in women.

Plozasiran significantly reduced triglycerides by 57% in severe hypertriglyceridemia, showing promise as a new treatment option.

New triple single-pill treatment lowers BP effectively and safely, simplifying early hypertension management in clinical practice.

Using heart age to guide treatment decisions could lead to inappropriate care, impacting both younger and older patients.

NT-proBNP strongly predicts atrial fibrillation risk, particularly in older adults, with implications for improved risk stratification.

Cardiac MRI reveals key risk factors for sudden cardiac events in Fontan patients, potentially guiding better clinical care.

Seasonal flu increases deaths and hospitalisations in heart failure patients, stressing the need for enhanced prevention.

Systematic review finds no increased intracranial haemorrhage risk with DOACs versus antiplatelets, reinforcing atrial fibrillation guidelines.

LGE imaging predicts sudden cardiac death in young HCM patients, improving risk models and informing clinical strategies.

Glycemic control influences brain connectivity and heart variability, with distinct age and sex differences in healthy adults.

VO2peak declines in Fabry disease, correlating with cardiomyopathy severity, suggesting its use as a marker for therapy response.

Novel study links coronary microvascular dysfunction to increased atherosclerotic plaque burden in INOCA, advancing cardiovascular insights.

Evolocumab improves endothelial function in cardiovascular patients, suggesting potential long-term benefits for heart health.

Stress echocardiography predicts five-year cardiovascular risk, guiding treatment for high-risk patients and offering reassurance for low-risk cases.

Alternative LDL cholesterol-lowering strategy offers similar outcomes to statins, with fewer side effects and better safety.

Systemic inflammation mediates psoriasis severity’s link to cardiovascular disease, highlighting its importance in clinical care.

Troponin monitoring reveals hidden cardiac risks in cancer immunotherapy, aiding early detection of myocarditis.

LA stiffness index correlates strongly with LVFPs in acute heart failure, showing superior diagnostic accuracy over standard measures, with potential to improve non-invasive management strategies.

Recaticimab cuts LDL-C by over 60% with 12-week dosing, offering a promising lipid-lowering option for nonfamilial hypercholesterolemia patients on stable statin therapy.

Kidney function decline in ATTR-CM predicts worse outcomes. Monitoring eGFR changes can guide interventions, improving clinical care for this progressive disease.

Ultrasound renal denervation delivers long-term blood pressure reductions and reduces medication reliance in resistant hypertension, study reveals.

Non-invasive ventilation offers safe, effective support in cardiogenic shock patients without the poor outcomes linked to invasive ventilation, according to a French registry study.

New analysis finds most pregnancy-related cardiovascular deaths preventable, highlighting racial disparities and offering prevention recommendations to improve maternal health.

Deep learning models accurately extract NYHA classifications and heart failure symptoms from clinical notes, offering a scalable solution for improved patient tracking and care.

A recent study reveals that heart failure with preserved ejection fraction is significantly underdiagnosed in patients with severe isolated tricuspid regurgitation. 

A genome-wide association study has identified 17 genetic loci linked to the risk of developing aortic stenosis, 11 of which show no association with coronary artery disease.

In adults with acute myocardial infarction (MI), acute anaemia was associated with a 25% higher risk of a composite outcome of 30-day death or recurrent MI compared to chronic anaemia

Data encompassing over 5.3 million participants showed that a heavier smoking history is associated with longer-lasting cardiovascular risks

Research has revealed that myocarditis is a significant consequence of COVID-19, with over half of recovered patients showing cardiac injury through cardiac magnetic resonance imaging

New research has revealed that SGLT2is are associated with an 18% reduction in total cardiovascular disease risk compared with DPP4is.

New research has demonstrated that in both men and women, as cardiovascular risk increases, the risk of migraine decreases…

Analysis of recurrent rejection (RR) in paediatric heart transplant recipients revealed that 17% of the population studied experienced RR.

A RECENT study found that multimodal, personalised teleprehabilitation significantly reduced major adverse cardiovascular events (MACE) in patients undergoing elective cardiac surgery.

New research has demonstrated that stationary behaviour, specifically prolonged sitting, is associated with increased risk of cardiovascular disease (CVD) and orthostatic circulatory disease.

New research has shown that nonstandard arm positions during blood pressure measurements significantly overestimate systolic and diastolic BP

COVID-19 vaccination is associated with a transient increase in cardiovascular risks, but complete vaccination significantly reduces the risk of more severe cardiovascular events.

Adults with epilepsy face double the risk of cardiovascular events, with enzyme-inducing antiseizure medications contributing significantly to this increased risk.

The venous excess ultrasound score improves mortality prediction in acute heart failure patients, offering a better assessment of venous congestion than traditional methods.

A study reveals a J-shaped link between mean heart rate and 30-day mortality in older ICU patients with sepsis. The lowest risk was observed for heart rates between 73 and 82 bpm,

Neurologic events following TAVR are linked to worse survival outcomes. Research highlights that strokes pose the greatest mortality risk.

The ESC 2024 TIGHT-K trial found that relaxed potassium control is just as effective as tight control for preventing atrial fibrillation post-CABG surgery.

A single-pill with four blood pressure drugs is more effective than a three-drug combo for resistant hypertension, per ESC Congress 2024.

ESC 2024: The SHAM-PVI trial confirms that catheter ablation significantly reduces atrial fibrillation burden and improves quality of life compared to a sham treatment.

ESC 2024: OCT-guided PCI in complex lesions reduced cardiac risks by 38% and spontaneous MI by 64% versus angiography, according to the OCCUPI trial.

Atrial fibrillation screening using a 14-day wearable heart monitor patch significantly increased diagnoses compared to usual care, according to research presented at ESC 2024.

The PROTEUS trial, presented at ESC 2024, evaluated the effectiveness of AI in standardizing clinician decision-making during stress echocardiography for coronary artery disease

Presented at ESC 2024, vutrisiran, an RNAi therapeutic, significantly reduced mortality and cardiovascular events in patients with ATTR-CM.

Integrating a polygenic score with clinical data improves predicting ascending aortic diameter and thoracic aortic events, outperforming traditional models.

Benzodiazepine usage has been associated with increased risk of coronary heart diseases heart failure, and cardiovascular death, according to recent research.

Researchers have determined that the benefit of bystander cardiopulmonary resuscitation on survival for out-of-hospital cardiac arrest is lowest in non-Hispanic Black individuals and women.

Ambient air pollution has been linked to an increased risk of all-cause death, hospital readmission, and burden of all-cause readmissions in patients with heart failure.

A multicentre study of 259 patients with prior CABG surgery found that post-PCI graft patency significantly predicts chronic total occlusion failure after PCI.

A new score to assess the risk of anthracycline-induced cardiovascular toxicity has been developed by researchers.

Wearable devices confirm digoxin is as effective as beta-blockers for heart rate control in atrial fibrillation patients.

Automated algorithms outperform manual ECG methods in accurately differentiating wide complex tachycardias into VT and supraventricular wide tachycardia, according to recent research.

Women with acute myocardial infarction and ventricular arrhythmias face higher in-hospital mortality and adverse outcomes compared to men

The gene RNF213 has been significantly associated with vasospastic angina and increased likelihood of mortality from acute myocardial infarction.

New study highlights the need for targeted anti-inflammatory treatments to reduce adverse cardiovascular events in high-risk patients.

A significant association has been established between pre-eclampsia and congenital heart disease in offspring.

A novel heart rate variability analysis method, detrended fluctuation analysis, outperforms conventional tools in predicting sudden cardiac death, according to recent research.

The risk of death is higher in patients with rheumatic heart disease in low/middle-income countries, with nearly 15% of patients dying within three years.

A recent study has compared the efficacy and safety of dual direct-current cardioversion (DDCV) with traditional single DCCV in patients with obesity.

Pre-eclampsia is associated with a higher risk of arrhythmias in primiparous females, according to new research.

Long-term risk of mortality and hospitalisation is a consequence of bacterial infection in survivors of drug use-associated infective endocarditis

New research has found an association between hypertension in youths and a 2.1 times higher risk of major adverse cardiac events

The interplay between time in target range and blood pressure variability of systolic blood pressure holds significance in assessing risks for major adverse cardiovascular events.

A recent study investigated the prevalence of hypertension among young adults experiencing palpitations.

A recent study found the difference between aortic blood pressure and brachial blood pressure can impact the diagnosis of hypertension.

New research suggests stair climbing could reduce mortality risk by 24% and cardiovascular death by 39%, urging its incorporation into daily routines for improved heart health and longevity.

Sex-related disparities in cardiovascular outcomes have been found in older adults with late-onset hypertension.

A new study shed light on the concerning risk factors and outcomes faced by individuals under 65 years old diagnosed with atrial fibrillation.

Researchers link hypertensive disorders in pregnancy to doubled risk of fatal cardiovascular disease up to a year post-birth, stressing the need for ongoing care and treatment strategies.

Adults with congenital heart disease who go on to develop arrhythmia disorders have been shown to have an increased risk of hospitalisation and mortality, according to new research. 

According to research, young adults taking stimulant medication for attention deficit hyperactivity disorder develop worse heart health, specifically a higher risk of developing cardiomyopathy.

Promoting a healthy lifestyle in children is paramount in driving development, quality of life, and long-term health. A new research identified a connection between cumulative sedentary time, PA, and cardiac function in adolescence.

A recent research study examined plaque in participants whom had undergone carotid endarterectomy for asymptomatic carotid artery disease

According to new data, cardiovascular disease risk for patients with gout is highest in females younger than 45 years old.

According to new research from the University of Pittsburgh, odds for survival after in-hospital cardiac arrest decline from 22% at 1 minute of CPR to less than 1% at 39 minutes.

A recent study found that South Korean females positive for high-risk human papillomavirus were almost four times as likely to die of atherosclerotic cardiovascular disease, compared with females without HPV infection.

A study, conducted by Fatemeh Omidi, Shahid Beheshti University of Medical Sciences, Tehran, Iran, and colleagues, reported a 20% reduced risk in cardiovascular death following influenza vaccination.

According to study, cardiology follow-ups (like cardiac MRI) should be implemented in patients with multisystem inflammatory syndrome in children. Read more.

Researchers reported that education is the leading social determinant of health, and recommend that paediatricians and other healthcare workers should pay attention to education in young patients.

According to research, AI appears to be able to predict atrial fibrillation within 1 month amongst patients with sinus rhythm. The algorithm used in this study was one of few developed to identify hidden AF in normal ECGs in diverse patients.

Vitamin D levels have been linked with an increased risk for atrial fibrillation, according to Xiaoli Ding, Gannan Medical University, China, and colleagues. This analysis incorporated data from five prospective cohorts. Read more.

The results of the Cardiac CARE trial reveal that troponin-guided carvedilol and candesartan intervention did not show any discernible impact on preserving cardiac function in patients undergoing chemotherapy.

Childhood sedentary behaviour has been linked to likelihood of experiencing an increase in left ventricular mass as young adults…